Vice President Research and Development
Huvepharma has been one of the market leaders in generic animal health pharmaceuticals. Under Christie’s direction, Huvepharma received approval for the first marketed Abbreviated New Animal Drug Application (ANADA) for Di-Methox (Sulfadimethoxine) Soluble Powder in 1993 under the Generic Animal Drug and Patent Term Restoration Act (GADPTRA). Huvepharma has received approval for a total of 12 ANADAs. They continue to be active in the development and marketing of generic pharmaceuticals through cooperative efforts with manufacturing partners.
Prior to joining Huvepharma in 1989, now Huvepharma,Christie worked for Medico Industries in Elwood, Kansas, a division of Tech America. He held supervisory and assistant manager positions in the oral liquids and parenteral department from 1974 through 1979 and became Director of Quality Assurance in 1980. During this tenure, he participated on the team that developed and received approval for over 30 New Animal Drug Applications (NADAs). He earned his Bachelor of Science degree in biology from Missouri Western State University in 1974.